Inventor · disambiguated record
Jiann-Shiun Lai
Also filed as: LAI JIANN-SHIUN
17 granted patents·12 pending applications·35 citations·filing 2008–2025
91Inventor score
Files withOBI PHARMA INC16DEV CT BIOTECHNOLOGY5DEV CENTER BIOTECHNOLOGY2LAI JIANN-SHIUN2LAI MING TAIN2
Top patents by PatentIndex Score
29 records- 0191US10815307B2Antibodies, pharmaceutical compositions and uses thereofOBI PHARMA INC·Filed 2017·Granted Oct 27, 2020·5 cites·9 claims
- 0290US11643456B2Human antibodies, pharmaceutical compositions and methodsOBI PHARMA INC·Filed 2017·Granted May 9, 2023·8 cites·32 claims
- 0388US11041017B2Antibodies, pharmaceutical compositions and methodsOBI PHARMA INC·Filed 2017·Granted Jun 22, 2021·4 cites·33 claims
- 0484US11000601B2Conjugated biological molecules, pharmaceutical compositions and methodsOBI PHARMA INC·Filed 2017·Granted May 11, 2021·2 cites·16 claims
- 0581US9428575B2Anti-granulysin antibodies and methods of use thereofDEV CT BIOTECHNOLOGY·Filed 2013·Granted Aug 30, 2016·5 cites·13 claims
- 0677US8252906B2Anti-herpes simplex virus antibodies and methods of use thereofLAI JIANN-SHIUN·Filed 2009·Granted Aug 28, 2012·3 cites·48 claims
- 0776US9902779B2Antibodies, pharmaceutical compositions and uses thereofOBI PHARMA INC·Filed 2015·Granted Feb 27, 2018·2 cites·11 claims
- 0874US10781266B2Antibodies specific to alpha-enolase and uses thereofDEV CT BIOTECHNOLOGY·Filed 2018·Granted Sep 22, 2020·1 cites·10 claims
- 0974US8431118B2Anti-herpes simplex virus antibodies and methods of use thereofLAI JIANN-SHIUN·Filed 2012·Granted Apr 30, 2013·2 cites·17 claims
- 1071US9527922B2Humanized alpha-enolase specific antibodies and methods of uses in cancer therapyDEV CT BIOTECHNOLOGY·Filed 2014·Granted Dec 27, 2016·2 cites·15 claims
- 1170US7763261B2Anti-human cytomegalovirus antibodiesDCB USA LLC·Filed 2008·Granted Jul 27, 2010·1 cites·12 claims
- 1269US12090212B2Conjugated biological molecules, pharmaceutical compositions and methodsOBI PHARMA INC·Filed 2020·Granted Sep 17, 2024·0 cites·8 claims
- 1365US11833223B2Antibodies, pharmaceutical compositions and methodsOBI PHARMA INC·Filed 2021·Granted Dec 5, 2023·0 cites·9 claims
- 1462US11236154B2Carbohydrate antibodies, pharmaceutical compositions and uses thereofOBI PHARMA INC·Filed 2019·Granted Feb 1, 2022·0 cites·17 claims
- 1558US10501532B2Carbohydrate antibodies, pharmaceutical compositions and uses thereofOBI PHARMA INC·Filed 2016·Granted Dec 10, 2019·0 cites·4 claims
- 1657US2025179191A1Bispecific dendritic cell engager and uses thereofLAI MING TAIN·Filed 2022·Application pending·0 cites
- 1756US2024084040A1Novel carbohydrate antibodies, pharmaceutical compositions and uses thereofOBI PHARMA INC·Filed 2022·Application pending·0 cites
- 1856US2024066125A1Globo series antigens-binding chimeric antigen receptors and uses thereofOBI PHARMA INC·Filed 2022·Application pending·0 cites
- 1955US10980894B2Antibodies, pharmaceutical compositions and methodsOBI PHARMA INC·Filed 2018·Granted Apr 20, 2021·0 cites·13 claims
- 2055US2025320299A1Bispecific dendritic cell engager and uses thereofOBI PHARMA INC·Filed 2025·Application pending·0 cites
- 2151US2016068595A1Humanized antibody against interleukin-20 and treatment for inflammatory diseasesDEV CENTER BIOTECHNOLOGY·Filed 2014·Application pending·0 cites
- 2250US2021093733A1Conjugated biological molecules, pharmaceutical compositions and methodsOBI PHARMA INC·Filed 2020·Application pending·0 cites
- 2349US2023056782A1Antibodies, pharmaceutical compositions and uses thereofLAI MING TAIN·Filed 2020·Application pending·0 cites
- 2448US2014314741A1Human Antibody against Interleukin-20 and Treatment for Inflammatory DiseasesDEVELOPMEN CT FOR BIOTECHNOLOGY·Filed 2013·Application pending·0 cites
- 2548US2020138967A1Combination therapy using anti-ssea-4 antibody in combination with therapeutic oncology agentsOBI PHARMA INC·Filed 2019·Application pending·0 cites
- 2644US10138300B2Anti-VEGFR antibody and uses thereofDEV CT BIOTECHNOLOGY·Filed 2017·Granted Nov 27, 2018·0 cites·10 claims
- 2742US2019389963A1Combination therapy by using anti-globo h or anti-ssea-4 antibody with anti-negative immune check points antibodyOBI PHARMA INC·Filed 2019·Application pending·0 cites
- 2839US2017233480A1Anti-vegfr antibody and uses thereofDEV CT BIOTECHNOLOGY·Filed 2016·Application pending·0 cites
- 2937US2016130336A1Anti-vegf antibodies and use thereofDEV CENTER BIOTECHNOLOGY·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →